Our first issue of 2022 is live! 🎉

Featuring trials in & a study on in a review on drug-drug interactions between targeted therapies & antifungals, and more! https://t.co/ncz5PtUKup

20 80

Our November issue is here! Featuring our joint Series with on in older people (https://t.co/LqBcyGyQAY), trials in myeloma & lymphoma, a study redefining low risk high hyperdiploidy in ped ALL, & much more

➡️https://t.co/EyrqUdHpyd

14 30

commission done for
and their partner Duke, this character lovingly referred to as a Thembo Hemonculous

4 14

Venetoclax-based regimens for NPM1-mutated

Read about it here👉https://t.co/7jgUWTy2sQ👈

4 13